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Enolase is secreted by Candida albicans and is present in its biofilms although its
extracellular function is unknown. Here we show that extracellular enolase mediates the
colonization of small intestine mucosa by C. albicans. Assays using intestinal mucosa
disks show that C. albicans adhesion is inhibited, in a dose dependent mode, either by
pretreatment of intestinal epithelium mucosa disks with recombinant C. albicans enolase
(70% at 0.5mg/ml enolase) or by pretreatment of C. albicans yeasts with anti-enolase
antibodies (48% with 20μg antiserum). Also using flow cytometry, immunoblots of
conditioned media and confocal microscopy we demonstrate that enolase is present in
biofilms and that the extracellular enolase is not an artifact due to cell lysis, but must
represent functional secretion of a stable form. This is the first direct evidence that
C. albicans’ extracellular enolase mediates colonization on its primary translocation site.
Also, because enolase is encoded by a single locus in C. albicans, its dual role peptide,
as glycolytic enzyme and extracellular peptide, is a remarkable example of gene sharing in
fungi.
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INTRODUCTION
The fungus Candida albicans is a member of the microbiota of
healthy individuals. However, in immunocompromised hosts it
causes infections ranging from superficial mucosal to invasive sys-
temic, usually fatal, manifestations (Odds et al., 1988; Dalle et al.,
2010). The ability to adhere to surfaces is essential for these infec-
tions, because it enables the colonization and invasion of specific
host niches. The gastrointestinal (GI) tract, although not exclu-
sive, is the main C. albicans reservoir in humans, from which sys-
temic infections are predominantly derived by translocation (Voss
et al., 1994; Nucci and Anaissie, 2001). Specialized enterocytes
(Goblet cells) secrete large amounts of mucus whose diversity
and rapid turnover play an important role in limiting the mul-
tiplication of Candida cells on the gastrointestinal tract (Senet,
1997; Scott and Hancock, 2000). C. albicans secretory aspartyl
proteinase, that degrades intestinal mucus, may contribute to
pathogenicity by facilitating the penetration of the mucus barrier
and the subsequent adhesion/invasion of epithelial cells (Colina
et al., 1996). The efficiency of these adhesion/invasion steps is
dependent on the expression of different C. albicans molecules
that interact with different host receptors. A variety of adhesins
are involved in binding to a wide array of proteins on the host’s
cell surfaces, including extracellular matrix components (ECM)
such as laminin, fibronectin, and fibrinogen (Senet, 1997).
Enolase is one of the most abundantly expressed cytosolic
enzymes in many organisms (Holland and Holland, 1978), and
considered a multifunctional protein, because it performs differ-
ent functions besides its primordial role in the glycolytic pathway
(Pancholi, 2001). This is gene sharing, where an unduplicated gene
acquires an additional function while maintaining its original one
in the same organism (Tracy and Hedges, 2000). For example,
enolase is also a heat shock protein involved in thermotolerance
and growth control of Saccharomyces cerevisiae (Iida and Yahara,
1985) and a structural component of crystallins in birds, lam-
preys, fishes and reptiles (Piatigorsky, 2003). As observed in many
other microorganisms and cells, C. albicans enolase can bind to
plasminogen and plasmin. A possible mechanism for its increased
ability to cross the human brain endothelial cells was proposed
(Jong et al., 2003). Also, several studies have shown that eno-
lase canmediate adhesion by interaction with extracellular matrix
proteins such as fibronectin and laminin, although the underly-
ing mechanisms are not fully understood (Carneiro et al., 2004;
Esgleas et al., 2008; Castaldo et al., 2009; Donofrio et al., 2009).
The enolase of C. albicans promotes a strong humoral immune
response in patients with invasive candidiasis (Strockbine et al.,
1984) and has been characterized as an important allergen in
inhalant allergies to fungi (Ito et al., 1995). Also, it can be detected
in culture medium and blood of patients (Sundstrom et al., 1994),
being an important marker for invasive candidiasis (Walsh et al.,
1991). It is also found on the cell surface (Eroles et al., 1997), in
association with glucans in the cell wall (Angiolella et al., 1996).
Although previous studies indicate that C. albicans enolase is
an immunodominant antigen (Angiolella et al., 1996), its pre-
cise role in C. albicans pathogenesis is still unknown. Here we
show that pretreatment of GI epithelia with enolase blocks adhe-
sion. Incubation of C. albicans with anti-enolase antibodies has a
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similar effect. We also demonstrate that enolase is secreted to the
extracellular medium and biofilms. Our data also show that extra-
cellular enolase derived from simple fungal lysis has a very short
half life outside the cells suggesting that the proper extracellular
form is not an artifact or an accidental leakage but it is actively
secreted. Here we provide for the first time a potential role for the
extracellular enolase in the gastrointestinal mucosae, the major
translocation site of C. albicans. Our findings also suggest a novel
example of gene sharing in fungi because enolase is encoded by
a single locus in C. albicans. From our data we predict that eno-
lase ligands might be present on the cell surface of the intestinal
epithelia or in the thick and complex structure of mucus covering
its surface.
MATERIALS AND METHODS
MICROORGANISMS AND GROWTH CONDITIONS
Unless otherwise stated, C. albicans strain SC5314, kindly pro-
vided by Dr. A. Mitchell—Carnegie Mellon University, USA;
C. albicans clinical isolate L296 (high biofilm-forming strain),
kindly provided by Dr. Arnaldo L. Colombo—UNIFESP, LEMI,
Brazil; Saccharomyces cerevisiae strain S288C, kindly provided by
Dr. Beatriz A. Castilho—UNIFESP, Brazil and the reference C.
albicans strain ATCC90029 (low biofilm-forming strain), were
grown in YPD medium (1% yeast extract, 2% peptone, 2%
dextrose) overnight with rotary agitation at 30◦C. Cells were
counted in a hemacytometer (Hirschmann EM Techcolor) and
adjusted to the desired concentration immediately before the
experiments. To produce hyphae, C. albicans yeasts were diluted
to 1.0 × 107 cells/ml in fetal bovine serum containing 5mg/ml
dextrose and incubated at 37◦C with agitation for 3 h. Escherichia
coli strain DH5-α was used for plasmid transformation. Strain
BL21 (DE3) was used for recombinant protein expression. E.
coli strains were grown overnight in LB medium supplemented
with 100μg/ml ampicilin or 15μg/ml kanamicyn at 37◦C with
constant agitation.
EXPRESSION AND PURIFICATION OF RECOMBINANT ENOLASE IN
E. coli
The complete coding region of C. albicans enolase gene
was PCR amplified from genomic DNA with the following
oligonucleotides: EnoexpresF:(5′-CGGGATCCATGTCTTACG
CCACTAAAATC-3′) and EnoexpresR: (5′-ATAGTTTAGCGGC
CGCTTACAATTGAGAAGCCTTT-3′). The insert was subcloned
between NotI and BamHI restriction sites in plasmid pET-28a
(+) (Novagen), in fusion with a Histidine tag at the N-terminal
portion according to (Sambrook et al., 1989). This construc-
tion was transformed into E. coli BL21 (DE3). An overnight
culture was inoculated into LB medium containing Kanamycin
(15μg/mL) and C. albicans enolase expression was then induced
with 1mM isopropyl-β-D-thiogalactopyranoside (IPTG) at 37◦C
for 2 h. After centrifugation, cells were lysed and the recombinant
protein (His6-enolase) was purified under native conditions in
pre-packed Ni-sepharose columns (Clontech) according to the
manufacturer’s instructions. The eluted protein was dialyzed
for 36 h at 15◦C against phosphate-buffered-saline (PBS) pH
7.6. Protein concentration was determined with the Bradford
assay (Bradford, 1976) and by SDS-PAGE analyses. To assess the
purity of the recombinant protein, samples were analyzed by
Coomassie blue and silver nitrate staining SDS-polyacrylamide
gel electrophoresis.
GENERATION OF POLYCLONAL SERA AGAINST His6-enolase
Purified His6−enolase was used to generate specific immune rab-
bit polyclonal sera. One hundred and fifty microgram of the
protein with complete and incomplete Freund’s adjuvant (Sigma)
for the first and the other two doses respectively, at 20-days inter-
vals, was subcutaneously injected in 2 adult female New Zealand
white rabbits. To obtain the pre-immune sera, aliquots of blood
were collected before the first immunization. Whole blood was
collected 55 days after the first immunization. Sera were obtained
by incubating the blood for 30min at 37◦C and overnight at 4◦C,
followed by centrifugation under 1000 rpm for 15min at 4◦C. All
sera were stored at −80◦C.
PREPARATION OF CELL LYSATES
5 × 108 yeasts were resuspended in lysis solution (20mM Tris pH
8.0, 2mMMgCl2, 2mM EGTA and 150mM NaCl) with protease
inhibitors (1mM phenylmethylsufonyl fluoride (PMSF), 2mM
benzamidin, 1μg/ml leupeptin, 10μg/ml pepstatin A, 4μg/ml
aprotinin, and 1μg/ml antipain) and phosphatase inhibitors
(10mM Sodium Pyrophosphate and 1mM Sodium Fluoride).
Cell suspensions were vortexed and lysis was done by sequential
freezing/thawing. After centrifugation at 13,000 rpm, for 15min
at 4◦C, the supernatant (soluble fraction) was separated from the
cellular debris and stored at −80◦C prior to each use. For spent
medium extraction, C. albicans SC5314 cultures in minimum and
YPD media were grown at 37◦C for 1–3 days. After incubation,
5ml of media were separated from cells by centrifugation, filtered
sterilized, concentrated 500× and frozen at −80◦C. E. coli cell
lysates of 107 cells were prepared by sequential freezing/boiling
procedures and the supernatant was separated from the cellu-
lar debris by centrifugation at 13,000 rpm for 5min at 4◦C, and
stored at −80◦C.
BIOFILM FORMATION AND PROTEIN MATRIX SEPARATION
C. albicans SC5314 biofilm was induced according to the proto-
col described elsewhere (Hawser and Douglas, 1994), with minor
modifications. Biofilms were grown on 150mm2 culture bottles,
using minimal medium (0.67% YNB, Difco) supplemented with
50mM glucose. Biofims were allowed to grow during 66 h, with
medium replacement every 24 h. The spent mediumwas removed
and biofilms were washed twice with 20ml of cold PBS to remove
non-adherent cells. 10ml of cold PBS were added into each bot-
tle and using cell scrappers, all biofilms and cells were detached
from the bottles. The biofilm suspension was vigorously vortexed
to disassemble cells from biofilm matrix, which were separated
by centrifugation at 4000 rpm, 8min, 4◦C. Biofilm matrix super-
natant was then filtered (0.22μm filters, TPP), concentrated 500
times using Centricon Plus–20 (5000mW—Millipore) and stored
at −80◦C.
WESTERN BLOT
Cell lysates and proteins were resuspended in 4 × Laemmli
buffer, boiled for 5min, separated by SDS-PAGE (Laemmli, 1970)
and transferred to poly (vinylidene difluoride) membranes (GE
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Healthcare) (Towbin et al., 1979). Membranes were blocked
overnight at 4◦C with 5% non-fat dry milk in PBS-0.1% tween 20
and probed with: Pre-immune rabbit serum (1:500 in PBS); anti-
His6-enolase (1:2000 in PBS); anti-His6-tag antibody—Santa
Cruz Biotechnology (1:1000 in PBS). Membranes were then incu-
bated with anti-rabbit IgG or anti-mouse IgG secondary antibod-
ies (Sigma) at 1:1000 for 1 h in an orbital shaker. Detection was
performed with the ECL-PLUS (GE Healthcare) according to the
manufacturer’s suggestions.
ENOLASE DECAY ASSAY
C. albicans SC5314 was grown in minimum medium at 37◦C
until the stationary phase. The culture was separated into two
batches. The first batch was then separated again. One flask was
maintained at room temperature and the other at 37◦C with-
out shaking for 5 h. The second batch was rapidly centrifuged
to separate the cells from conditioned medium, filtered and then
separated again. One flask was maintained at room temperature
and the other at 37◦C without shaking for 5 h. Aliquots of 5ml
were removed in different time points: 0min, 30min, 1, 2, 3, 4,
and 5 h, concentrated 500 times (to 10μl) and stored at −80◦C.
FLOW CYTOMETRY
C. albicans SC5314 was grown in YPD medium, overnight, at
37◦C and 200 rpm. Two aliquots of 107 yeasts were separated. The
first aliquot was fixed in 3.5% formaldehyde for 1 h, washed in
PBS and incubated overnight with anti His6-enolase (diluted 1:80
in PGN + 1% saponin) (permeabilized cells). The second aliquot
was first incubated with anti His6-enolase without saponin and
then was fixed (non-permeabilized). After consecutive washes
in PBS, cells were incubated with anti-rabbit IgG marked with
fluorescein (FITC) (diluted 1:100 in PBS) for one 1 h, at room
temperature. After two washes, the number of yeasts was esti-
mated with a fluorescent cytometer Becton-Dickinson, counting
104 cells. As a control, permeabilized and non-permeabilized cells
were incubated with pre-immune rabbit serum. For the enolase
uptake assay, a culture of C. albicans SC5314 was processed as
described above. Five aliquots of 2 × 104 cells were separated.
The first aliquot was incubated overnight at 4◦C with the elution
buffer of the recombinant protein purification and the other four
aliquots were incubated with different concentrations of His6-
enolase: 1.25, 2.5, 5, and 10μg. After washes with PBS, cells were
fixed with 3.5% paraformaldehyde for 1 h. Then, cells were incu-
bated with anti-His6 (diluted 1:20 in PGN) for 1 h, washed and
incubated with anti-rabbit-IgG labeled with FITC (diluted 1:50
in PBS). As control, the recombinant enolase was coupled to
latex beads (100μg of His6-enolase to 108 beads) and incubated
in coupling buffer (200mM sodium carbonate, 500mM sodium
chloride, pH 8.5) overnight, at 37◦C, with agitation. Beads were
subsequently washed and blocked with BSA solution in PBS
(20mg/ml) and then incubated with anti-His6 (diluted 1:20 in
PGN) for 1 h. After this period, they were washed and incubated
with anti-mouse IgG labeled with FITC (diluted 1:50 in PGN).
After two washes cells were analyzed in a Becton-Dickinson flow
cytometer (10,000 events).
IMMUNOFLUORESCENCE MICROSCOPY
C. albicans were centrifuged, washed with PBS and fixed with
3.5% formaldehyde in PBS for 1 h. After incubation, cells were
washed at least five times with PBS and then 10μl were dripped
on to glass slides to dry at room temperature. For biofilm for-
mation, glass slides were coated with poly-lysine (10mg/ml)
(Sigma), dried and the biofilm was formed according to the pro-
tocol previously described. Slides containing yeasts, hyphae and
biofilm were permeabilized with 1% saponin (BDH, Amersham,
UK) in PGN (0.2% gelatin, 0.1% NaN3 in PBS) or incubated
only with PGN for blocking (non-permeabilized cells) for 15min.
The coverslips were incubated with anti-His6-enolase (diluted
1:80 in PGN or PGN + saponin) overnight at 4◦C and washed
with PBS. They were subsequently incubated with anti-rabbit-IgG
conjugated with Cy3 (Sigma) diluted 1:100 in calcofluor white
(10mg/ml) for 1 h, in the dark. After washing with PBS, cover-
slips were mounted in glycerol buffered with 100mM Tris pH
8.6 and 0.1% p-phenylenediamine. Slides were examined under
a confocal microscope (BioRad 1024-UV) coupled to a Zeiss
Axiovert 100 microscope. Alternatively, images were acquired in
an epifluorescence microscope.
ADHESION ASSAYS
The adhesion assays were based on a modification of the protocol
previously described by (Segal and Sandovskylosica, 1995). Five
week-oldmale Balb/cmice were purchased fromUniversity of São
Paulo - USP, Brazil. Experiments were performed in accordance
with guidelines for animal use and care of the Federal University
of São Paulo—UNIFESP and approved by the Ethics Committee
in Research. Mice were maintained in pathogen free conditions
and aged 8–12 weeks for the experiments. Mouse integral intes-
tine was aseptically removed from sacrificed animals and a cut of
approximately 0.4 inches was done after the end of the stomach
and before the caecum. The small intestine (duodenum, jejunum,
and ileum) was cut longitudinally, rinsed once in sterile PBS to
remove aggregates and opened on a flat surface. Mice intesti-
nal tissue disks (6mm in diameter) were obtained with a sterile
metal punch. Inhibition of C. albicans adhesion to mouse intesti-
nal disks coated with recombinant enolase was performed as
follows: disks were added to eppendorf tubes containing increas-
ing concentrations of His6-enolase to a final volume of 1ml in
PBS. These tubes were then incubated for 2 h at 37◦C in an
orbital shaker. Disks were rinsed twice in PBS, added to eppen-
dorf tubes containing 2.5 × 106 C. albicans in PBS and incubated
for 2 h at 37◦C. Disks were rinsed 5 times to remove non adherent
cells, homogenized and eluted in 1ml of PBS. Pre-coated C. albi-
cans adhesion assays were performed by preincubating 5.2 × 106
C. albicans yeasts with different concentrations of purified anti
His6-enolase for 2 h at 37◦C. Cells were centrifuged at 3000 g
for 3min at 4◦C, washed 3 times and eluted. Disks were added
to cell suspensions and processed as previously described. All
elutions were serially diluted and plated on YPD medium con-
taining 34μg of chloramphenicol/ml. Plates were incubated for
48 h at 30◦C, and the number of attached microorganisms per
tissue disk was estimated by counting C. albicans colony forming
units (cfu).
RESULTS
POTENTIAL ROLE OF BIOFILM ENOLASE
The intracellular role of enolase as a glycolytic pathway enzyme
is widely known. To investigate its potential extracellular role,
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suggested by its presence in the biofilm matrix, we produced
a recombinant C. albicans enolase (Figure 1) and an anti-His6-
enolase polyclonal rabbit serum. We found that native enolase
can be detected in the biofilm matrix of C. albicans SC5314
and in cell lysates of three different C. albicans strains includ-
ing the SC5314, one clinical isolate identified as a high biofilm
producer (L296) and a reference strain that is a low biofilm
producer (ATCC90029), used as control (Padovan et al., 2009)
(Figure 1C). Only one band was observed in the biofilm matrix
and also the homologous enolase in the cell lysate of S. cerevisiae
S288C. A weaker signal was observed after 3 days in YPDmedium
(Figure 1C).
ENOLASE IS PRESENT ON THE CELL SURFACE
Since it has been reported that enolase is present on the cell sur-
face of yeasts (Pancholi, 2001), we tested the ability of the anti
His6-enolase polyclonal rabbit serum to detect cell surface eno-
lase in biofilm-forming cells. Flow cytometry data (Figure 2A)
showed that enolase could be detected on the surface of 14% non-
permeabilized yeasts cells, while in permeabilized cells; enolase
FIGURE 1 | Native enolase is recognized in C. albicans cell lysates,
biofilm and supernatant of conditioned rich medium. Western blots of
enolase in biofilm and cell lysates of different C. albicans strains, according
to: NI, non-induced E. coli BL-21 lysate; I, E. coli BL-21 expression induced
for 2 h at 37◦C lysate; 1, recombinant His6-enolase; 2, His6-T. cruzi 30 kDa
protein used as control; 3, S. cerevisiae 288c cell lysate; 4, C. albicans
SC5314 cell lysate; 5, C. albicans ATCC90029 cell lysate, 6, C. albicans
L296 cell lysate; 7, C. albicans SC5314 biofilm matrix concentrated 500
times; C. albicans SC5314-conditioned medium are respectively: 8, minimal
medium with 24 h growth; 9, minimal medium with 72 h growth; 10, YPD
with 24 h growth; and 11, YPD with 72 h growth. (A) anti-His6 antibody
(dilution 1:1000), shows the recognition of the recombinant protein of
His6-T. cruzi and the His6-enolase, confirming its proper purification; (B)
pre-immune rabbit serum (1:500), showing no recognition of fungal
proteins and recognition of a non-specific low molecular weight band
(below 37 kDa) within the E. coli extracts; and (C) anti His6-enolase
(1:2000), showing recognition of the recombinant enolase and native
protein in biofilms, cell lysates and spent medium.
was detected in 40% (Figure 2B). The growth conditions of
cells used in this experiment (see Flow cytometry) might have
induced the formation of germ-tubes and pseudo-hyphae, pos-
sibly explaining the flatline shift in fluorescence observed in
Figures 2A,B. To verify whether cells in the biofilm also had eno-
lase on their surface, immunofluorescence microscopy images
of yeasts and hyphae were compared with biofilms (Figure 3).
Figures 3A–D show that enolase was not recognized by the pre-
immune serum. Figures 3E–H show enolase covering the cell sur-
face of non-permeabilized yeasts. Diffused and stronger labeling
was observed in permeabilized cells (Figure 3K) although several
cells were not labeled. Figures 3M,N showed strong enolase signal
in permeabilized biofilm-forming cells, both in yeasts attached to
the slide, at the basal layer, as in hyphae and buds at the upper part
of the biofilm. Non-permeabilized biofilm-forming cells exhib-
ited less enolase signal on their surface (Figures 3O,P). Strikingly,
in non-permeabilized biofilm-forming cells, the co-localization of
enolase with calcofluor occurred in a few cells. These data support
previous findings that enolase is present on the cell surface of C.
albicans yeasts and indicate for the first time that enolase is also
present on the surface of hyphae and biofilm-forming cells (yeasts
and hyphae).
BIOFILM ENOLASE IS NOT DERIVED FROM LEAKAGE OF DEAD CELLS
It could be argued that the presence of enolase in the biofilm
matrix is a consequence of cytoplasm leakage of dead cells at
the bottom layers of the biofilm, and therefore there would be
no specific function for enolase in the biofilm matrix. To test
whether native enolase could be detected in stationary cultures,
FIGURE 2 | Flow cytometry of enolase detected on yeast surface and in
the whole cell. (A) C. albicans SC5314 fixed and non-permeabilized cells
were incubated with anti-His6-Enolase polyclonal serum (1:80), present
slightly higher fluorescence (red line) than the relative fluorescence
background of the untreated control cells (black line). (B) C. albicans
SC5314 fixed and permeabilized cells with saponin 1% exhibit higher
fluorescence (green line) compared with non-permeabilized cells. 104 cells
were analyzed per experiment. On average, 10% of them exhibited
autofluorescence that were discounted of the experimental measurements
highlighted in the red (non-permeabilized cells) and green (permeabilized
cells) boxes in the final analysis. Black boxes depict the subtraction of
fluorescence by autofluorescence values (Approximately 14 and 40% for
non-permeabiled and permeabilized cells, respectively).
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FIGURE 3 | Immunofluorescence of native enolase detected in yeasts,
hyphae and biofilm-forming cells of C. albicans SC5314.
Immunofluorescence of yeasts permeabilized with saponin 1%: (A) DAPI
(1:2000); (B) Pre-immune serum (1:80); (C) Merged images and (D)
Phase contrast image. Immunofluorescence of non-permeabilized yeast
and filaments cells: (E) DAPI (1:2000); (F) anti His6-enolase polyclonal
serum (1:80); (G) Merged images and (H) Phase contrast image.
Filaments permeabilized with saponin 1%: (I) DAPI (1:2000); (J) anti
His6-enolase polyclonal serum (1:80); (K) Merged images and (L) Phase
contrast image. Presence of enolase in biofilm cells permeabilized with
saponin 1% and incubated with anti His6-enolase polyclonal serum (1:80):
(M) immunofluorescence microscopy overlaid with phase contrast of the
bottom part of the biofilm enriched with yeasts; (N) immunofluorescence
microscopy overlaid with phase contrast of the upper part of the biofilm
enriched with hyphae cells. Immunofluorescence microscopy images
merge of enolase in non permeabilized biofilm cells stained with
calcofluor white (CW) (1:200) and incubated with anti His6-enolase
polyclonal serum (1:80): (O) bottom part of the biofilm with budding
yeasts highly covered with enolase; (P) upper part of the biofilm enriched
with hyphae. Bars: 10μm.
C. albicans SC5314 was grown in minimal medium until reaching
the stationary phase and aliquots of the culture medium with and
without cells were taken from 0.5, 1, 2, 3, 4, and 5 h to check for
the presence of native enolase. A decay in native enolase levels was
observed at room temperature, with or without cells (Figure 4A),
while a much faster decay was observed at 37◦C at 30min, espe-
cially in the cell-free conditioned medium (Figure 4B). To test
whether cytosolic proteins could be detected in the biofilm due to
cell lysis, we checked for the presence of Sui2p (eIF2α—The alpha
subunit of the eukaryotic translation initiation factor 2), a cyto-
plasmic protein of S. cerevisiae. The S. cerevisiae Sui2p has 84% of
similarity and 70% identity with itsC. albicans homolog, CaSui2p
(orf19.6213). We detected Sui2p and CaSui2p in cell extracts of S.
cerevisiae andC. albicans, respectively, while in conditionedmedia
it was weakly detected and not detected at all in the biofilmmatrix
(Data not shown).
SHORT HALF-LIFE OF DEAD CELL LEAKED ENOLASE IS NOT EXPLAINED
BY REUPTAKE
Because enolase was detected on the cell surface of planktonic
yeasts and hyphae and on biofilm forming cells, the enolase decay
could also be explained by the enolase uptake from the external
medium to the cell wall. To test this hypothesis, cultures of C.
albicans SC5314 were incubated with 4 different concentrations
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FIGURE 4 | Western blots of the kinetics of C. albicans SC5314 enolase
decay in conditioned media. Aliquots of 5ml conditioned minimal
medium (CM) only and stationary cultures (w/ = with cells) were
maintained at room temperature (A) and at 37◦C (B), without agitation.
Samples were removed and analyzed by western blot (Probed with anti
His6-enolase). Numbers indicate the time interval of sampling in hours.
of His6-enolase and its presence on the cell surface of yeasts was
assessed by flow cytometry. Figure 5 shows that there was no
recognition of the recombinant enolase on the surface of C. albi-
cans cells in all the concentrations tested (1.25–10μg), as opposed
to His6-enolase coated beads. These data suggest that enolase
present on the cell surface is not a product of protein uptake from
cell debris lysis.
Taken together the results above suggest that enolase in the
biofilm matrix is not a product of cell lysis because it would
be rapidly degraded at 37◦C as occurred in yeast cell cultures
(Figure 4B). Therefore enolase might be functionally secreted to
the extracellular environment such as biofilms and to the cell sur-
face where it is stable. These results also indicate that the presence
of enolase on the cell surface is not a result of protein uptake from
cell debris lysis.
BLOCKING OF CELL SURFACE ENOLASE WITH ANTI-ENOLASE INHIBITS
C. albicans ADHESION TO MICE GI TISSUE DISKS
To investigate the role of cell surface enolase in adhesion, we first
checked whether C. albicans yeasts preferentially associates with
specific parts of mice small intestine in vitro. There was no dif-
ference in the number of yeasts adhering to disks obtained from
three equal portions (proximal, medial and distal third parts) of
small intestine tissues (Figure S1 supplemental). Therefore, we
employed disks prepared from the whole small intestine in all
our assays. C. albicans yeasts were pre-incubated with different
concentrations of affinity-purified rabbit anti-serum and then
incubated with mice GI tissue disks. There was no difference in
the number of yeasts per tissue disks whenC. albicanswas blocked
with the pre-immune serum or with the anti His6-CaYlr39cp
(an antibody against the intracellular protein CaYlr339cp), used
as a negative control. On the other hand, blocking C. albicans
with 10 and 20μg of anti His6-enolase decreased its adhesion to
mice GI tissue disks to approximately 42 and 47 % respectively,
in relation to anti His6-CaYlr339cp (Figure 6A). The inhibition
FIGURE 5 | Flow cytometry of C. albicans SC5314 incubated with
purified enolase (enolase uptake assay). (A) Control beads coated with
His6-enolase were incubated with anti-His6-tag (1:80) (blue line) compared
with C. albicans SC5314 incubated with the elution buffer of His6-enolase
(black line). (B) Yeasts incubated with 1.25μg of His6-enolase and
subsequently incubated with anti-His6-tag (1:80) (no signal). (C) Yeasts
incubated with 10μg of His6-enolase and incubated as (B) (no signal).
of adhesion seemed to saturate when 10μg of antibodies were
used since twice of its concentration did not decrease proportion-
ately the adhesion of yeasts to GI disks. In an attempt to verify
if the decrease in adhesion observed was not due to the poten-
tial recognition and blockage of surface proteins rich in histidine
regions in C. albicans, yeasts were also blocked with a monoclonal
anti-His6-Tag antibody. There was no difference in adhesion in
relation to the negative control (Data not shown). Also, viability
assays indicated that this inhibition was not dependent on poten-
tial candidacidal activities promoted by the polyclonal antiserum
raised against recombinant enolase (Figure S2 supplemental).
These results indicate that the blockage of enolase present on the
cell surface of C. albicans with specific antibodies against enolase
impairs its adhesion to mice GI disks in vitro.
INHIBITION OF C. albicans ADHESION TO MICE GI TISSUE DISKS BY
PURIFIED RECOMBINANT ENOLASE
Since the coating of cell surface enolase with antibodies was able
to inhibit C. albicans yeasts adhesion to GI disks in vitro, we
hypothesized that blocking potential enolase receptors on disks
might also have an effect on C. albicans adhesion. To test this
hypothesis, mice GI tissue disks were pre-incubated with different
concentrations of recombinant His6-enolase. After incubation,
disks were washed and then incubated with C. albicans yeasts.
Strikingly, the incubation of disks with 0.5mg of soluble purified
His6-enolase inhibited C. albicans adhesion to GI disks at 70%
in comparison to the purified protein His6-CaYlr339cp, used as
a negative control. The decreased adhesion was dose dependent
because incubation of disks with 0.1 and 0.2mg of enolase inhib-
ited adhesion in 39 and 52 % respectively (Figure 6B). There was
no difference in the number of attached C. albicans cells per disk
in relation to disks incubated with His6-CaYlr339cp in PBS or
PBS alone. Together, these results indicate that recombinant eno-
lase may be blocking specific host enolase receptor(s) on mice GI
disks, thus inhibiting the adhesion of C. albicans.
DISCUSSION
We identified enolase in C. albicans biofilms by mass spectrom-
etry of SDS-PAGE bands in an initial attempt to study biofilm
composition (data not shown). Using western blot and confocal
microscopy we confirmed this observation and also identified for
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FIGURE 6 | Inhibition of C. albicans adhesion to mice gastrointestinal
(GI) tissue disks. (A) Preincubation of C. albicans yeasts strain SC5314
with different concentrations of purified polyclonal anti His6-enolase (10
and 20μg) inhibited its adhesion to GI disks in comparison with the
negative controls (20μg of polyclonal purified anti His6-CaYlr339cp or
pre-immune serum). Data represent mean number of cells per tissue
disks × (103) based on colony-forming units (cfu) counting of three
independent experiments performed in triplicate. Bars represent the
standard error (SE) of the means. Percentage values above the bars
represent the percentage inhibition of adhesion with the negative control
(anti His6-CaYlr339cp) considered as 0%. (B) Pretreatment of disks with
increasing concentrations of the recombinant protein His6-enolase (0.1–0.5
mg) inhibited C. albicans strain SC5314 adhesion in a dose dependent
manner in comparison with the negative controls (disk incubated with
0.5mg of His6-CaYlr339cp in PBS or PBS alone). Data represent mean
number of cells per tissue disks × (103) based on colony-forming units
(cfu) counting of three independent experiments performed in triplicate.
Bars represent the standard error (SE) of the means. Percentage values
above the bars represent the percentage inhibition of adhesion with the
negative control (His6-CaYlr339cp) considered as 0%.
the first time enolase in biofilm forming cells, buds and grow-
ing hyphae of C. albicans (Figures 1–3). In its cytosolic form,
enolase is a protein of approximately 48 kDa, which catalyzes
the dehydration of 2-phosphoglycerate to generate phospho-
enolpyruvate in the glycolytic pathway and the reverse reaction
in gluconeogenesis (Sundstrom and Aliaga, 1992) but its func-
tion in the biofilm, whether structural or regulatory, is still
unknown. Our results confirmed previous studies demonstrat-
ing enolase in biofilms (Thomas et al., 2006) and in planctonic
cells (Angiolella et al., 1996), and provided for the first time
evidence of extracellular enolase in biofilm forming cells and
hyphae. Interestingly, enolase seems to migrate with a slightly
larger molecular weight in the biofilm matix relative to the
enolase detected in whole cell extracts of C. albicans, suggest-
ing that enolase is being post-translationally modified in the
biofilm. Further studies are necessary to address this question.
Our FACS analysis and immunoblots of conditioned media sug-
gested that enolase presence within the extracellular milieu is
probably functional and not artifactual, e.g., by lysis of dead
cells (Figures 2, 4, 5). To address the function of the extracellu-
lar enolase we devised adhesion assays using yeasts coated with
anti-enolase antibodies and mice GI disks coated with purified
enolase. Our results clearly show an important effect of inhibi-
tion in both types of experiments. These assays are a modification
of the assay described by Segal and Sandovskylosica (1995), and
was carried out using mice small intestine tissue disks, compris-
ing the duodenum, jejunum and ileum. Because no differences
in adhesion were observed among three equal portions of the
small intestine (Figure S1 supplemental), the whole small intes-
tine portion was used in all experiments herein. These assays
allowed us to demonstrate how preincubation of disks with eno-
lase and of C. albicans with anti-enolase antibodies block the
adhesion. The intestinal serosa comprise a large portion of the
intestinal disks, therefore it could be argued thatC. albicanswould
also adhere to this portion. However, it was previously demon-
strated that yeasts preferentially attach to the mucosa and only a
limited number of organisms attach to the serosa, making this
technique a much more realistic in vitro model to the actual
in vivo phenomenon of attachment (Sandovskylosica and Segal,
1989).
Inhibition of C. albicans adhesion is one of the most well doc-
umented activities mediated by antibodies, and distinct levels
of inhibitions toward many cell wall antigens have already been
described (Cotter et al., 1998; Laforce-Nesbitt et al., 2008). In this
work, we demonstrated a role for cell surface enolase in adhesion
by blocking C. albicans with a specific anti-enolase antibody. We
found that neutralization of cell surface enolase inhibits its adhe-
sion to mice GI tissue disks. The saturation of inhibition observed
indicates that multiple C. albicans molecules mediate the adhe-
sion to gastrointestinal disks in vitro. Our experiments also show
that these results were not biased by possible direct candidacidal
activity of antibodies (Figure S2 supplemental) or by the induc-
tion of germ tubes formation by antiserum or by contact with
tissue disks in vitro (data not shown). The decrease in adhesion
by anti-enolase antibodies is not without precedent. Blocking of
cell surface enolase from Paracoccidioides brasiliensis (Donofrio
et al., 2009), and Streptococcus suis (Esgleas et al., 2008) inhibited
their adhesion to pulmonary epithelial and brain microvascular
endothelial cells respectively.
To further characterize the role of enolase on adhesion, mice
GI tissue disks were incubated with recombinant enolase in an
attempt to mask possible receptor binding sites on host tissues.
Pretreatment of GI disks strongly inhibited C. albicans adhesion
in a dose-dependent manner (Figure 6B). Incubation of C. albi-
cans with the recombinant enolase indicated that the inhibition
observed is not a consequence of possible cytotoxic contaminants
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on the purified protein (data not shown). An important inhi-
bition of C. albicans adhesion was also observed by Segal and
Savage after pretreatment of mice duodenal disks with chitin sol-
uble extracts (Segal and Savage, 1986). Our data are in line with a
previous study reporting a decrease in adhesion of S. suis, serotype
two, to epithelial cells exposed to recombinant enolase (Zhang
et al., 2009). Altogether these results suggest that enolase directly
interacted to specific epithelial receptors on mice intestinal disks,
thus inhibiting C. albicans adhesion.
The intestinal mucosa comprises an epithelial layer arranged
in individual columns. It is composed of two fractions: a loosely
adherent layer easily removable by suction and a layer firmly
attached to the mucosa, which actually constitutes the intestinal
epithelial cells glycocalyx (Hecht, 1999; Scott and Hancock, 2000;
Atuma et al., 2001). C. albicans can associate directly to epithe-
lium cells or to the mucus layer covering these cells (Kennedy
et al., 1987). In view of this fact and the report showing the asso-
ciation of Streptococcus mutans enolase to a highly glycoysylated
oral mucin in vitro (Ge et al., 2004), it is possible to speculate that
enolase could be binding to glycoproteins covering the epithelium
or even to loosely adherent mucus, therefore inhibiting C. albi-
cans adhesion. However, we do not exclude the possibility that
enolase might have inhibited the adhesion by modifying mucosal
properties or host receptors (Freter and Jones, 1983), rendering
Candida cells unable to bind to intestinal disks. Further research
is required to determine the specific host receptor(s) involved
in such interaction. Since the adherence of C. albicans to differ-
ent surfaces is paramount for biofilm formation, it is possible
that enolase expressed on the surface of biofilm-forming cells
could also contribute to the adhesion of C. albicans to different
substrates with potential implications for biofilm adhesion and
formation. Further experiments are required to test this hypoth-
esis. Nevertheless, based on our data, we propose that the C.
albicans enolase present on the cell surface is functional and does
not represent an artifact. We also propose that surface enolase
plays an important role in adhesion of C. albicans in its major
translocation site. Also, because enolase is encoded by a single
gene in C. albicans genome, its dual role as a glycolytic enzyme
and as an extracellular component, exemplifies an interesting and
novel case of gene sharing in fungi.
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